EconomyAll India Radio News · official
NPPA caps trade margins on 137 anti-cancer drugs
BANKING · UPSC · SSC
National Pharmaceutical Pricing Authority (NPPA) capped trade margins on MRP of 137 anti-cancer drugs, based on the recommendations of Expert Committee constituted by the Directorate General of Health Services (DGHS) under Ministry of Health & Family Welfare.
Exam-ready takeaways
- As on date, 76 pharmaceutical companies have reported revised MRP for 1225 anti-cancer formulations, covering 121 drugs.
- Reduction in the MRP have been reported in 1031 formulations of anti-cancer medicines, with 600 brands reporting above 50% reduction and the highest reduction being 96.45%.
- Further, out of the 137 identified anti-cancer drugs, there are 10-15 drugs which are yet to be launched in India.
- As a result of the price reductions to be effected from today, the estimated annual savings to consumers would be ₹3,502.31 crore.
Recall the report
Fill the missing fact
Try the gap before opening the answer. These exercises use the report’s own wording; they are practice prompts, not past exam questions.
Reduction in the MRP have been reported in 1031 formulations of anti-cancer medicines, with 600 brands reporting above [ … ] reduction and the highest reduction being 96.45%.
Reported answer: 50%
Reduction in the MRP have been reported in 1031 formulations of anti-cancer medicines, with 600 brands reporting above 50% reduction and the highest reduction being 96.45%.
As a result of the price reductions to be effected from today, the estimated annual savings to consumers would be [ … ].
Reported answer: ₹3,502.31 crore
As a result of the price reductions to be effected from today, the estimated annual savings to consumers would be ₹3,502.31 crore.
Turn this news into marks